Navigation Links
Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer
Date:1/9/2009

National Cord Blood Program Provides Stem Cells

NEW YORK, Jan. 9 /PRNewswire-USNewswire/ -- A two year old child from Florida is free of signs of juvenile myelomonocytic leukemia (JMML), a very rare form of pediatric leukemia, seventeen months after receiving a transplant with cord blood from the National Cord Blood Program (NCBP) of the New York Blood Center's Howard P. Milstein National Cord Blood Center.

Juvenile myelomonocytic leukemia generally affects children under the age of five and comprises less than one percent of infant leukemias. The prognosis for JMML is generally poor and most children with JMML die before reaching the age of three.

Adolfo Gonzalez was diagnosed with JMML when he was thirteen months old. "Adolfo Gonzalez would most likely not be alive today if it weren't for the cord blood transplant," said Gary Kleiner, M.D., Ph.D., pediatric immunologist at the University of Miami School of Medicine. "The mother who donated her cord blood to the public cord blood bank at New York's National Cord Blood Program basically saved his life."

Adolfo's treatment included chemotherapy to destroy his leukemia cells followed by a cord blood stem cell transplant from NCBP. He did endure some complications, but approximately two weeks after he had received the infusion of the stem cells, his white cell count began to return to normal. Adolfo has no signs of any leukemia seventeen months later.

"We're thrilled that NCBP, the first and largest public cord blood bank in the world, was able to help Adolfo and his family," said NCBP Chief Scientist Pablo Rubinstein, M.D. "He's among almost 3,000 people who have received a match from the 50,000 units we've frozen since 1992."

Note: WCTV in Tallahassee, Florida conducted an in-depth interview with Dr. Kleiner. A full transcript, along with Dr. Kleiner's media contact information, is available at this link:

http://www.wctv.tv/medicalminute/interviewheadlines/36761699.html

About National Cord Blood Program (NCBP)

Launched in 1992, NCBP was the first established cord blood bank to collect, process, test and store cord blood units and make them available for transplantation for any patient in need for a hematopoietic stem cell transplant. NCBP accepts requests from all over the world. Cord blood units can be accessed through the NETCord database, and now through the Single Point of Access (SPA) of the National Marrow Donor Program.

About New York Blood Center (NYBC)

New York Blood Center (NYBC) is one of the nation's largest non-profit, community-based blood centers. NYBC has been providing blood, transfusion products and services to patients in greater New York since 1964. NYBC is also home to the Lindsley F. Kimball Research Institute and the National Cord Blood Program at the Howard P. Milstein National Cord Blood Center, the world's largest public cord blood bank. NYBC provides medical services and programs (Clinical, Transfusion, and Hemophilia Services) through our medical professionals and transfusion medicine physicians.

    Contact: Christine Dingfelder
    (212) 570-3227 Office / (917) 763-1648 Cell



'/>"/>
SOURCE New York Blood Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CCA Industries, Inc. Declares Its Seventeenth Consecutive Dividend
2. Lee County School District online wellness program inspires employees to walk 200 million steps in 2 months
3. Mammogram most effective 12 months after radiation treatment
4. Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter
5. Miami Clinic Owner Sentenced to 30 Months in Prison for $10.9 Million Medicare Fraud
6. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
7. International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results
8. Mindray Announces 2008 Third Quarter and Nine Months Results
9. Miami Physician Sentenced to 84 Months in Prison for $26.2 Million Medicare Fraud
10. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
11. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , ... May 24, 2016 , ... How to Write ... Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major ... human error will ever be totally eliminated, many human performance problems can be prevented. ...
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health (LLUH) has officially broken ... Children’s Hospital. Over 3,000 people looked on as the shovels hit the dirt at ... slidehsow. , During the program, Richard H. Hart, MD, DrPH, president, LLUH, recapped ...
(Date:5/24/2016)... ... May 24, 2016 , ... Eggsurance, ... the official relaunch of its community and education hub for women considering fertility ... is to create a safe and welcoming place for women to find cycle ...
(Date:5/24/2016)... ... May 24, 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, powered ... Young Living Essential Oils, taught by Patti Dolan, RYT, a Young Living Gold ... Flow is 6:30pm - 7:15pm followed by a small intro to the Oils that ...
(Date:5/24/2016)... ... May 24, 2016 , ... In light of recent heavy flooding in Houston, ... contaminated well water throughout the Houston area. , Heavy floodwaters have led to destroyed ... to contaminants. Residents may not even be aware of the contamination of their water ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 2016 Global Paclitaxel Market 2016 ... 12 companies and the Paclitaxel analysis in this study ... industry and its players. This is the ... details the current state of the industry while providing ... applications and industry chain structure. The Paclitaxel market analysis ...
(Date:5/23/2016)... May 23, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 ... Other), by Application (Drug Discovery and Development, Proteomics, ... (Pharmaceuticals, Life Science and Biotechnology, Academic and Research ... Research, the global mass spectrometry market ...
(Date:5/23/2016)... , May 23, 2016 ... for detection of multiple diseases; ,Technology to be presented ... Yissum Research Development Company of the Hebrew ... into a research agreement with Aurum Ventures MKI, the technology ... development of a new diagnostic approach for early detection ...
Breaking Medicine Technology: